Koers Ambu A/S Nasdaq Copenhagen
Aandelen
DK0060591204
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 5,38 mld. 784 mln. 721 mln. | Omzet 2025 * | 6,07 mld. 883 mln. 812 mln. | Marktkapitalisatie | 34,06 mld. 4,96 mld. 4,56 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 467 mln. 67,98 mln. 62,53 mln. | Nettowinst (verlies) 2025 * | 636 mln. 92,59 mln. 85,16 mln. | EV/omzet 2024 * | 6,37 x |
Nettoschuld 2024 * | 215 mln. 31,23 mln. 28,72 mln. | Nettoliquiditeiten 2025 * | 279 mln. 40,59 mln. 37,34 mln. | EV/omzet 2025 * | 5,57 x |
K/w-verhouding 2024 * |
72,9
x | K/w-verhouding 2025 * |
53,6
x | Werknemers | - |
Dividendrendement 2024 * |
0,2% | Dividendrendement 2025 * |
0,28% | Vrij verhandelbaar | 64,63% |
Recentste transcriptie over Ambu A/S
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 51 | 17-12-19 | |
Director of Finance/CFO | 40 | 01/01 | |
Finn Möhring
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jørgen Jensen
CHM | Chairman | 56 | 09-12-20 |
Christian Sagild
BRD | Director/Board Member | 64 | 01-01-12 |
Director/Board Member | 54 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,46% | 179 mld. | |
+3,39% | 113 mld. | |
-3,68% | 67,88 mld. | |
+5,44% | 52,03 mld. | |
+5,70% | 43,3 mld. | |
+4,03% | 41,79 mld. | |
+25,42% | 32,49 mld. | |
+14,00% | 25,65 mld. | |
-4,29% | 24,55 mld. |